Literature DB >> 17032194

Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease.

Alexandra Gutierrez1, Hang Lee, Bruce E Sands.   

Abstract

OBJECTIVE: Abdominal and pelvic abscesses are a common complication of Crohn's disease. We studied the effect of the initial choice of therapy on time to resolution of abdominal and pelvic abscesses.
METHODS: We recorded clinical, laboratory, and radiographic data on all adult patients with Crohn's disease and abdominal or pelvic abscesses treated at our institution from 1991 to 2001 and followed > or = 1 yr. Univariate analysis identified variables associated with initial choice of drainage modality. These variables were included in a Cox regression model to identify factors independently associated with time to resolution.
RESULTS: Of 66 episodes identified, surgery was the initial modality in 29 and percutaneous drainage in 37. Median time to resolution was not different between surgical drainage (25.0 days, range 0-240) and percutaneous drainage (21.5 days, range 0-182) (p = 0.084). Older age, longer duration of symptoms prior to drainage, no fistula identified radiographically, immune modulator use, no rebound tenderness, and admission to the medical service were factors associated with percutaneous drainage as initial modality. These factors, when incorporated in a Cox regression model, did not significantly affect the time to resolution. Days from onset of symptoms to radiographic diagnosis or drainage were independently associated with time to resolution of the abscess.
CONCLUSION: Time to resolution of abdominal or pelvic abscesses in Crohn's disease is similar with percutaneous drainage and surgery. One-third of patients treated with percutaneous drainage required surgery within 1 yr. Earlier intervention for abdominal and pelvic abscesses is associated with shorter time to resolution.

Entities:  

Mesh:

Year:  2006        PMID: 17032194     DOI: 10.1111/j.1572-0241.2006.00757.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  36 in total

Review 1.  [Surgery in Crohn's disease].

Authors:  K Horisberger; P Kienle
Journal:  Chirurg       Date:  2015-11       Impact factor: 0.955

Review 2.  Computed tomography-guided percutaneous abscess drainage in coloproctology: review of the literature.

Authors:  R Golfieri; A Cappelli
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

Review 3.  Role of radiology in geriatric care: a primer for family physicians.

Authors:  Jeremy O'Brien; Mark O Baerlocher; Murray Asch; Andy Myers
Journal:  Can Fam Physician       Date:  2009-01       Impact factor: 3.275

Review 4.  Intra-abdominal abscess drainage: interval to surgery.

Authors:  Jong Park; Hearns W Charles
Journal:  Semin Intervent Radiol       Date:  2012-12       Impact factor: 1.513

5.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

Review 6.  Preoperative optimization of crohn disease.

Authors:  Amit Sharma; Bertram T Chinn
Journal:  Clin Colon Rectal Surg       Date:  2013-06

Review 7.  Surgery and diagnostic imaging in abdominal Crohn's disease.

Authors:  Fiorenzo Botti; Flavio Caprioli; Diego Pettinari; Alberto Carrara; Andrea Magarotto; Ettore Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-16

8.  Colonic Crohn's disease.

Authors:  Steven Mills; Michael J Stamos
Journal:  Clin Colon Rectal Surg       Date:  2007-11

9.  Preoperative optimization of Crohn's disease.

Authors:  Jonathan E Efron; Tonia M Young-Fadok
Journal:  Clin Colon Rectal Surg       Date:  2007-11

10.  Pyogenic complications of Crohn's disease, evaluation, and management.

Authors:  James W Fleshman
Journal:  J Gastrointest Surg       Date:  2008-09-23       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.